Medicare Enrolled

Dr. Eric Orzeck, MD

Endocrinology · Houston, TX
Low-engagement
10023 S MAIN ST, Houston, TX 77025
7137979922
In practice since 2005 (20 years)
NPI: 1356342406 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Orzeck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orzeck? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Orzeck

Dr. Eric Orzeck is an endocrinology in Houston, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Orzeck received a total of $42,147 from 76 pharmaceutical and/or device companies across 855 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Orzeck is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $42,147 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$42,147
Total received (2018-2024)
Avg $6,021/year across 7 years
Top 16% in TX for endocrinology
76
Companies
855
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,674 (51.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,265 (36.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,208 (12.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,906
2023
$2,033
2022
$2,210
2021
$3,294
2020
$3,205
2019
$9,423
2018
$19,076

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$17,260
Amgen Inc.
$3,359
Janssen Pharmaceuticals, Inc
$2,896
Lilly USA, LLC
$2,309
AstraZeneca Pharmaceuticals LP
$2,126
SANOFI-AVENTIS U.S. LLC
$1,953
Amarin Pharma Inc.
$1,183
MannKind Corporation
$692
Corcept Therapeutics
$641
VERTEX PHARMACEUTICALS INCORPORATED
$533
Esperion Therapeutics, Inc.
$522
Medtronic MiniMed, Inc.
$512
Boehringer Ingelheim Pharmaceuticals, Inc.
$495
Shire North American Group Inc
$445
Mannkind Corporation
$442
Tandem Diabetes Care, Inc.
$441
CeQur Corporation
$413
Daiichi Sankyo Inc.
$359
Xeris Pharmaceuticals, Inc.
$342
Abbott Laboratories
$323
Novartis Pharmaceuticals Corporation
$289
AbbVie, Inc.
$272
Dexcom, Inc.
$251
Aytu BioScience, Inc
$248
Radius Health, Inc.
$228
AbbVie Inc.
$203
Intuity Medical Inc
$178
Takeda Pharmaceuticals U.S.A., Inc.
$171
Amneal Pharmaceuticals LLC
$166
Gemini Laboratories, LLC
$165
Madrigal Pharmaceuticals
$144
Horizon Therapeutics plc
$131
Bayer Healthcare Pharmaceuticals Inc.
$130
Kowa Pharmaceuticals America, Inc.
$125
Akcea Therapeutics, Inc.
$122
Otsuka America Pharmaceutical, Inc.
$122
Bayer HealthCare Pharmaceuticals Inc.
$117
Insulet Corporation
$117
RECORDATI_RARE_DISEASES_INC.
$114
Allergan Inc.
$110
IBSA Pharma Inc.
$102
DEXCOM, INC.
$88
PFIZER INC.
$85
Mallinckrodt Enterprises LLC
$85
Merck Sharp & Dohme Corporation
$85
Ultragenyx Pharmaceutical Inc.
$83
Alexion Pharmaceuticals, Inc.
$80
ABBVIE INC.
$72
Verity Pharmaceuticals Inc.
$64
Amryt Pharma Holdings Ltd
$54
ARBOR PHARMACEUTICALS, INC.
$53
Becton, Dickinson and Company
$52
Zealand Pharma US, Inc.
$45
Scilex Pharmaceuticals Inc.
$42
Currax Pharmaceuticals LLC
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
Medtronic, Inc.
$35
Nevro Corp.
$34
Antares Pharma, Inc.
$33
Neurocrine Biosciences, Inc.
$30
Gilead Sciences, Inc.
$28
Ascendis Pharma Inc
$26
KVK-Tech, Inc.
$25
Curium US LLC
$22
Kyowa Kirin, Inc.
$21
EUSA Pharma (US) LLC
$21
Endo Pharmaceuticals Inc.
$19
Amphastar Pharmaceuticals, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$18
Aegerion Pharmaceuticals, Inc.
$17
EISAI INC.
$17
Merck Sharp & Dohme LLC
$16
TheracosBio, LLC
$13
Emergent BioSolutions Inc.
$13
Eisai Inc.
$12
BETA BIONICS, INC.
$10
Top 3 companies account for 55.8% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BASAGLAR · BD Nano · BOTOX · BYDUREON · Belviq · Brenzavvy · CONTRAVE · CRYSVITA · CYCLOSET · CeQur Simplicity · Crysvita · Cryvista · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Detectnet · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre Pro · GATTEX · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · Horizant · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JUXTAPID · Juxtapid · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Narcan · Natesto · Norditropin · OFIRMEV · OTREXUP · Omnia · Omnipod · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RESMETIROM · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SAMSCA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Sogroya · Strensiq · Sylvant · Synthroid · TEGSEDI · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VPRIV · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEPBOUND · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a endocrinology in Houston?
Compare endocrinologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
148
Per 100K population
3.1
County median income
$73,104
Nearest hospital
WOMANS HOSPITAL OF TEXAS,THE
1.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Orzeck is a endocrinology, and high industry engagement (low-engagement, top 16%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Orzeck receive payments from pharmaceutical companies?
Yes. Dr. Orzeck received a total of $42,147 from 76 companies across 855 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Orzeck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →